Revolutionizing cancer treatment? A conversation on the potential of personalized cancer vaccines

Lauren Coyle, Commissioning Editor, Immuno-Oncology Insights, speaks with Roy de Souza and David Hawke, co-founders of BreakBio, about innovative strategies for personalized cancer vaccines and the transformative potential of early intervention in cancer.

CORRIGENDUM In the version of this Interview initially published, Roy de Souza expressed his opinion on the challenges companies have faced in the development of personalized cancer vaccines (pp 68–69); however, this has since altered. To reflect this change, we have amended the HTML and PDF versions of this article as of May 30, 2024.

Please enter your email to access content Read now